Published 2011
| Version v1
Publication
Imatinib treatment induces CD5+ B lymphocytes and IgM natural antibodies with anti-leukemic reactivity in patients with chronic myelogenous leukemia.
Additional details
- URL
- http://hdl.handle.net/11567/390433
- URN
- urn:oai:iris.unige.it:11567/390433
- Origin repository
- UNIGE